These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30400214)

  • 1. Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.
    Huang H
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for ligand reception by anaplastic lymphoma kinase.
    Li T; Stayrook SE; Tsutsui Y; Zhang J; Wang Y; Li H; Proffitt A; Krimmer SG; Ahmed M; Belliveau O; Walker IX; Mudumbi KC; Suzuki Y; Lax I; Alvarado D; Lemmon MA; Schlessinger J; Klein DE
    Nature; 2021 Dec; 600(7887):148-152. PubMed ID: 34819665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ALK receptor in sympathetic neuron development and neuroblastoma.
    Janoueix-Lerosey I; Lopez-Delisle L; Delattre O; Rohrer H
    Cell Tissue Res; 2018 May; 372(2):325-337. PubMed ID: 29374774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of anaplastic lymphoma kinase in pediatric cancers.
    Takita J
    Cancer Sci; 2017 Oct; 108(10):1913-1920. PubMed ID: 28756644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for the activation of the anaplastic lymphoma kinase receptor.
    Reshetnyak AV; Rossi P; Myasnikov AG; Sowaileh M; Mohanty J; Nourse A; Miller DJ; Lax I; Schlessinger J; Kalodimos CG
    Nature; 2021 Dec; 600(7887):153-157. PubMed ID: 34819673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic lymphoma kinase: Role in cancer and therapy perspective.
    Zhao Z; Verma V; Zhang M
    Cancer Biol Ther; 2015; 16(12):1691-701. PubMed ID: 26529396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic lymphoma kinase as a therapeutic target in anaplastic large cell lymphoma, non-small cell lung cancer and neuroblastoma.
    Cheng M; Ott GR
    Anticancer Agents Med Chem; 2010 Mar; 10(3):236-49. PubMed ID: 20406193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatan sulphate is an activating ligand of anaplastic lymphoma kinase.
    Machino M; Gong Y; Ozaki T; Suzuki Y; Watanabe E; Imagama S; Kadomatsu K; Sakamoto K
    J Biochem; 2021 Dec; 170(5):631-637. PubMed ID: 34270745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and targeting of anaplastic lymphoma kinase in cancer.
    Della Corte CM; Viscardi G; Di Liello R; Fasano M; Martinelli E; Troiani T; Ciardiello F; Morgillo F
    Mol Cancer; 2018 Feb; 17(1):30. PubMed ID: 29455642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
    Werner MT; Zhao C; Zhang Q; Wasik MA
    Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting anaplastic lymphoma kinase in neuroblastoma.
    Umapathy G; Mendoza-Garcia P; Hallberg B; Palmer RH
    APMIS; 2019 May; 127(5):288-302. PubMed ID: 30803032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.
    Webb TR; Slavish J; George RE; Look AT; Xue L; Jiang Q; Cui X; Rentrop WB; Morris SW
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):331-56. PubMed ID: 19275511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
    Pearson ADJ; Barry E; Mossé YP; Ligas F; Bird N; de Rojas T; Zimmerman ZF; Wilner K; Woessmann W; Weiner S; Weigel B; Venkatramani R; Valteau D; Trahair T; Smith M; Singh S; Selvaggi G; Scobie N; Schleiermacher G; Richardson N; Park J; Nysom K; Norga K; Merino M; McDonough J; Matloub Y; Marshall LV; Lowe E; Lesa G; Irwin M; Karres D; Gajjar A; Doz F; Fox E; DuBois SG; Donoghue M; Casanova M; Caron H; Buenger V; Bradford D; Blanc P; Barone A; Reaman G; Vassal G
    Eur J Cancer; 2021 Nov; 157():198-213. PubMed ID: 34536944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
    Guan J; Umapathy G; Yamazaki Y; Wolfstetter G; Mendoza P; Pfeifer K; Mohammed A; Hugosson F; Zhang H; Hsu AW; Halenbeck R; Hallberg B; Palmer RH
    Elife; 2015 Sep; 4():e09811. PubMed ID: 26418745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the ALK receptor in cancer biology.
    Hallberg B; Palmer RH
    Ann Oncol; 2016 Sep; 27 Suppl 3():iii4-iii15. PubMed ID: 27573755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.
    Sattu K; Hochgräfe F; Wu J; Umapathy G; Schönherr C; Ruuth K; Chand D; Witek B; Fuchs J; Li PK; Hugosson F; Daly RJ; Palmer RH; Hallberg B
    FEBS J; 2013 Nov; 280(21):5269-82. PubMed ID: 23889739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma.
    Li T; Deng Y; Shi Y; Tian R; Chen Y; Zou L; Kazi JU; Rönnstrand L; Feng B; Chan SO; Chan WY; Sun J; Zhao H
    Oncogene; 2018 Nov; 37(47):6180-6194. PubMed ID: 30013190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.
    He D; Lasek AW
    Mol Pharmacol; 2020 Feb; 97(2):123-131. PubMed ID: 31734646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
    Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
    J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic lymphoma kinase as a therapeutic target.
    Kruczynski A; Delsol G; Laurent C; Brousset P; Lamant L
    Expert Opin Ther Targets; 2012 Nov; 16(11):1127-38. PubMed ID: 22998583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.